Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1991-4-4
pubmed:abstractText
Cytotoxic microspheres have been developed for intra-arterial use in patients with liver metastases. Following injection, the distribution of microspheres reflects the pattern of hepatic arterial blood-flow. Vasoactive agents, such as angiotensin II, by producing vasoconstriction in normal liver, might divert arterial blood toward tumour and thereby enhance the delivery of drug-loaded particles. Using a double isotope technique, the distribution of radiolabelled microspheres to tumour and normal liver tissue was measured before and after angiotensin II infusion in nine patients with multiple liver metastases. The median increase in tumour: normal ratio following angiotensin II infusion was by a factor of 2.8 (range 0.8-11.7, P less than 0.05). This novel approach to regional chemotherapy, using a combination of angiotensin II infusion and cytotoxic microspheres, increases the exposure of tumour to cytotoxic agents and may, therefore, enhance tumour response rates.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-14450081, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-2522549, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-2933831, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-2971418, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-2981143, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-3349299, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-3358909, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-3449788, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-3828954, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-3917365, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-3921079, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-4053012, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-443905, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-597163, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-6166362, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-6787705, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-7063703, http://linkedlifedata.com/resource/pubmed/commentcorrection/1997111-7356531
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
308-10
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour.
pubmed:affiliation
University Department of Surgery, Royal Infirmary, Glasgow, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't